Paradigm Asset Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$141K Sell
2,919
-1,700
-37% -$79.3K 0.03% 297
2025
Q4
$224K Hold
4,619
0.05% 269
2025
Q3
$218K Hold
4,619
0.05% 264
2025
Q2
$223K Hold
4,619
0.06% 263
2025
Q1
$256K Hold
4,619
0.07% 244
2024
Q4
$223K Sell
4,619
-200
-4% -$10.2K 0.06% 253
2024
Q3
$278K Sell
4,819
-300
-6% -$16.2K 0.07% 245
2024
Q2
$248K Hold
5,119
0.07% 248
2024
Q1
$249K Hold
5,119
0.06% 267
2023
Q4
$255K Hold
5,119
0.07% 281
2023
Q3
$275K Buy
5,119
+200
+4% +$10.7K 0.08% 264
2023
Q2
$265K Sell
4,919
-2,307
-32% -$124K 0.07% 267
2023
Q1
$393K Sell
7,226
-21,568
-75% -$1.05M 0.11% 235
2022
Q4
$1.39M Buy
28,794
+2,818
+11% +$124K 0.39% 58
2022
Q3
$988K Buy
25,976
+2,000
+8% +$89.1K 0.33% 77
2022
Q2
$1.2M Sell
23,976
-6,100
-20% -$324K 0.37% 64
2022
Q1
$1.54M Hold
30,076
0.41% 63
2021
Q4
$1.51M Buy
30,076
+5,376
+22% +$266K 0.38% 83
2021
Q3
$1.19M Buy
+24,700
New +$1.26M 0.33% 103

Other funds holding SNY

Paradigm Asset Management's SNY Position: Q1 2026 in Review

Paradigm Asset Management reduced its Sanofi (SNY) stake by 37% in Q1 2026, selling an estimated $79.3K and leaving 2,919 shares worth $141K. The position accounts for 0.03% of the portfolio, ranked #297.

Paradigm Asset Management first reported a position in SNY in Q3 2021 and has held it in 19 quarters since. The position peaked at $1.54M in Q1 2022. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Paradigm Asset Management held 2,919 shares of Sanofi worth $141K as of Q1 2026.
  • Paradigm Asset Management sold 1,700 Sanofi shares in Q1 2026, an estimated $79.3K.
  • Sanofi made up 0.03% of Paradigm Asset Management's portfolio in Q1 2026, its #297 holding.
  • Paradigm Asset Management first reported a position in Sanofi in Q3 2021 and has held it in 19 quarters since.
  • Paradigm Asset Management's Sanofi position peaked at $1.54M in Q1 2022.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Paradigm Asset Management's 13F filing for Q1 2026, filed 12 May 2026.